These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 6382440
1. Neurobiological and neuroendocrine functions of the vasoactive intestinal peptide (VIP). Rostène WH. Prog Neurobiol; 1984; 22(2):103-29. PubMed ID: 6382440 [No Abstract] [Full Text] [Related]
4. A new neuroregulator: the vasoactive intestinal peptide or VIP. Rosselin G, Maletti M, Besson J, Rostène W. Mol Cell Endocrinol; 1982 Aug; 27(3):243-62. PubMed ID: 6290287 [Abstract] [Full Text] [Related]
5. Autoradiographic analysis of the distribution of vasoactive intestinal peptide binding sites in the vertebrate central nervous system: a phylogenetic study. Dietl MM, Hof PR, Martin JL, Magistretti PJ, Palacios JM. Brain Res; 1990 Jun 18; 520(1-2):14-26. PubMed ID: 2169952 [Abstract] [Full Text] [Related]
8. Involvement of vasoactive intestinal polypeptide in NMDA-induced phase delay of firing activity rhythm in the suprachiasmatic nucleus in vitro. Shibata S, Ono M, Tominaga K, Hamada T, Watanabe A, Watanabe S. Neurosci Biobehav Rev; 1994 Jun 18; 18(4):591-5. PubMed ID: 7708374 [Abstract] [Full Text] [Related]
9. Cerebral vascular adenylate cyclase: evidence for coupling to receptors for vasoactive intestinal peptide and parathyroid hormone. Huang M, Rorstad OP. J Neurochem; 1984 Sep 18; 43(3):849-56. PubMed ID: 6086840 [Abstract] [Full Text] [Related]
10. VIP: Possible functions as a neural peptide. Said SI, Giachetti A, Nicosia S. Adv Biochem Psychopharmacol; 1980 Sep 18; 22():75-82. PubMed ID: 6104904 [No Abstract] [Full Text] [Related]
11. Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig. Robberecht P, Tatemoto K, Chatelain P, Waelbroeck M, Delhaye M, Taton G, De Neef P, Camus JC, Heuse D, Christophe J. Regul Pept; 1982 Oct 18; 4(5):241-50. PubMed ID: 6294750 [Abstract] [Full Text] [Related]
12. Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems. Imura H, Fukata J, Mori T. Clin Endocrinol (Oxf); 1991 Aug 18; 35(2):107-15. PubMed ID: 1934523 [No Abstract] [Full Text] [Related]
13. Vasoactive intestinal peptide in the hypothalamus and pituitary. Lam KS. Neuroendocrinology; 1991 Aug 18; 53 Suppl 1():45-51. PubMed ID: 1901391 [Abstract] [Full Text] [Related]
14. Analysis of peptide histidine-isoleucine/vasoactive intestinal polypeptide-immunoreactive neurons in the central nervous system with special reference to their relation to corticotropin releasing factor- and enkephalin-like immunoreactivities in the paraventricular hypothalamic nucleus. Hökfelt T, Fahrenkrug J, Ju G, Ceccatelli S, Tsuruo Y, Meister B, Mutt V, Rundgren M, Brodin E, Terenius L. Neuroscience; 1987 Dec 18; 23(3):827-57. PubMed ID: 3125490 [Abstract] [Full Text] [Related]
17. The role of vasoactive intestinal polypeptide (VIP) as a hypothalamic neurohormone. Nicosia S, Oliva D, Giannattasio G, Spada A. J Endocrinol Invest; 1983 Jun 18; 6(3):235-42. PubMed ID: 6311891 [No Abstract] [Full Text] [Related]
18. Antagonism of vasoactive intestinal peptide mRNA in the suprachiasmatic nucleus disrupts the rhythm of FRAs expression in neuroendocrine dopaminergic neurons. Gerhold LM, Sellix MT, Freeman ME. J Comp Neurol; 2002 Aug 19; 450(2):135-43. PubMed ID: 12124758 [Abstract] [Full Text] [Related]
20. Cholecystokinin and vasoactive intestinal polypeptide in the mammalian CNS: distribution and possible physiological roles. Emson PC, Hunt SP, Rehfeld JF, Golterman N, Fahrenkrug J. Adv Biochem Psychopharmacol; 1980 Aug 19; 22():63-74. PubMed ID: 6994447 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]